D9 - Tetrahydrocannabiphorol-O Acetate - D9-THCPO

D9-THCPO isolate is a specialist cannabinoid acetate derivative for professional technical evaluation. This product page is intended for qualified B2B buyers, formulators and quality teams assessing material identity, batch documentation and a defined market route—not for consumer-use or medical guidance. Confirm current availability, specification and destination-market requirements with Pharmabinoid before making a sourcing decision.

Product identity and commercial fit

Names used for emerging cannabinoid derivatives can be inconsistent. Buyers should confirm the exact chemical identity, nomenclature, batch reference and analytical basis for any material under review. Do not infer that data for D9-THCP, THC-O acetate or another related compound applies to D9-THCPO. The material should be assessed against its own specification and the intended finished-product category.

For a professional evaluation, define the role of the isolate in the project first: analytical reference or R&D screening, formulation feasibility, or a later commercial assessment subject to legal and quality approval. Sample review does not by itself establish suitability for manufacture, sale or use in any particular country.

Specification and formulation review

Request the current batch specification and confirm that it identifies the material, assay method, reported potency or purity basis, relevant related compounds, storage conditions and retest or expiry information where available. Do not assume that solubility, melting behaviour, processing temperature, carrier compatibility or stability data for a different cannabinoid derivative will apply. Establish those parameters using an appropriately designed and documented evaluation for the actual batch and proposed formulation.

• Identity: Confirm the name, structure or reference standard basis and batch traceability.
• Analytical fit: Ask whether the method can distinguish the target from related isomers, derivatives and potential process impurities.
• Formulation: Evaluate compatibility, homogeneity, packaging interaction and stability for the intended matrix; do not extrapolate from another ingredient.
• Scale-up: Agree acceptance criteria and change-control expectations before planning repeat supply.

Quality assurance and batch documentation

Review a certificate of analysis (COA) that corresponds to the exact batch being considered. Assess the method, reference materials, limits of quantification and reporting conventions—not just the headline result. Depending on the intended product and applicable quality system, request relevant contaminant testing, such as residual solvents, pesticides, heavy metals or microbiological tests, and confirm which tests are actually included rather than assuming a full panel.

Keep the COA, specification, safety information, sample evaluation and supplier correspondence together in the project file. If a test cannot confidently identify the target compound or resolve relevant related substances, obtain clarification from a qualified analytical laboratory before proceeding.

Regulatory review, handling and storage

Regulatory status is jurisdiction- and product-category-specific. Before purchase, import, manufacture, promotion or sale, have qualified compliance personnel assess the destination country, intended route, applicable restrictions and permitted claims. This page is not a legal determination and does not establish that D9-THCPO is authorized for any particular use or market.

Follow the batch-specific safety data, handling instructions and storage guidance supplied for the material. Keep containers appropriately identified and controlled, protect the material as directed by its documentation, and record receipt, sampling and storage conditions. Do not use the ingredient in a consumer product unless the responsible quality and regulatory teams have confirmed the relevant requirements.

Availability and purchasing checks

Product and variant availability can change. Confirm the live offer, available pack sizes, minimum order quantities, lead time, shipping route and documentation package directly before placing an order. Where the storefront shows a variant as unavailable, contact the team to ask whether a current supply option exists; do not treat a product listing as a guarantee of stock or delivery.

For a quotation or technical discussion, share your intended format, target market, estimated volume, required tests and launch timing. Pharmabinoid can then clarify the current supply information and identify what further documentation or review may be needed.

Related technical resources

Compare category information on the D9-THCPO products collection and review the cautious evidence summary on D9-THCPO research and studies. For commercial questions, use the Pharmabinoid contact page.

Next step

Before moving forward, confirm material identity, batch-specific evidence, formulation requirements and the intended legal market route with your internal quality and compliance teams. Contact Pharmabinoid with those requirements to discuss current availability and a suitable B2B next step.